Description
Product details
GLYCOPRESS glycopyrrolate glycopyrronium inhalation solution 25 mcg GLYCOPRESS™ is a precision-formulated inhalation solution containing 25 mcg of glycopyrrolate (also known as glycopyrronium), a long-acting bronchodilator designed to help individuals manage chronic respiratory conditions. Glycopyrrolate belongs to a class of medications known as long-acting muscarinic antagonists (LAMAs). These medicines work by relaxing the muscles surrounding the airways, allowing them to remain open for easier breathing. GLYCOPRESS™ is primarily prescribed for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is intended for regular, long-term use and is delivered via a nebulizer system, ensuring consistent and controlled medication delivery directly into the lungs. This inhalation solution is developed to provide sustained bronchodilation, improved airflow, and enhanced respiratory comfort for patients who require ongoing airway management. How GLYCOPRESS™ Works The active ingredient in GLYCOPRESS™, glycopyrrolate, works by blocking the action of acetylcholine at muscarinic receptors in the bronchial smooth muscle. Acetylcholine is a neurotransmitter that causes airway muscles to constrict. By inhibiting its action, glycopyrrolate helps prevent bronchospasm (tightening of the airway muscles). This mechanism results in: Relaxation of bronchial smooth muscles Reduced airway resistance Improved airflow Easier breathing As a long-acting bronchodilator, GLYCOPRESS™ provides sustained airway dilation, making it suitable for daily maintenance therapy rather than immediate relief of sudden breathing problems. Indications and Uses GLYCOPRESS™ is indicated for: Maintenance treatment of chronic obstructive pulmonary disease (COPD) Management of chronic bronchitis Management of emphysema Long-term bronchodilation therapy It is important to note that GLYCOPRESS™ is not a rescue medication. It should not be used for sudden episodes of shortness of breath. Patients should continue to carry a fast-acting rescue inhaler for acute bronchospasm episodes. Key Benefits of GLYCOPRESS™ 1. Long-Lasting Bronchodilation GLYCOPRESS™ provides sustained airway relaxation, helping maintain open airways throughout the day when used as prescribed. 2. Improved Breathing Comfort By reducing airway constriction, patients often experience reduced shortness of breath, wheezing, and chest tightness. 3. Enhanced Lung Function Regular use may lead to measurable improvements in lung capacity and airflow over time. 4. Reduced Exacerbations Consistent bronchodilation can help lower the frequency and severity of COPD flare-ups. 5. Convenient Nebulized Delivery The inhalation solution format ensures medication reaches deep into the lungs, especially beneficial for patients who struggle with handheld inhalers. 6. Targeted Action Because the medication is inhaled directly into the lungs, systemic exposure is minimized compared to oral medications, potentially reducing widespread side effects. 7. Non-Steroidal Option GLYCOPRESS™ does not contain corticosteroids, making it suitable for patients seeking bronchodilation without steroid exposure. Dosage and Administration GLYCOPRESS™ (25 mcg) should be used exactly as prescribed by a healthcare professional. The inhalation solution is administered via a standard nebulizer device. General usage guidelines: Use at the same time each day. Do not exceed the prescribed dose. Do not swallow the solution. Rinse the mouth after inhalation if advised by your healthcare provider. Clean the nebulizer equipment after each use to maintain hygiene and prevent contamination. Patients should never abruptly discontinue therapy without consulting their healthcare provider. Possible Side Effects Like all medications, GLYCOPRESS™ may cause side effects. While many patients tolerate glycopyrrolate well, some may experience mild to moderate reactions. Common Side Effects Dry mouth Throat irritation Cough Headache Nasal congestion Mild dizziness These effects are usually manageable and may decrease as the body adjusts to the medication. Less Common but Serious Side Effects Difficulty urinating Blurred vision Increased heart rate (tachycardia) Worsening of glaucoma symptoms Severe allergic reactions (rash, swelling, difficulty breathing) Patients with a history of narrow-angle glaucoma, urinary retention, or prostate enlargement should use GLYCOPRESS™ with caution and under medical supervision. If sudden worsening of breathing occurs immediately after use (paradoxical bronchospasm), discontinue the medication and seek medical attention immediately. Precautions and Warnings Before starting GLYCOPRESS™, inform your healthcare provider if you: Have glaucoma Have urinary retention issues Have prostate enlargement Have kidney problems Are pregnant or breastfeeding Are using other anticholinergic medications Drug interactions may occur when used alongside other anticholinergic drugs, potentially increasing side effects such as dry mouth or urinary retention. GLYCOPRESS™ should be stored at room temperature and kept away from direct sunlight and moisture. Keep out of reach of children. Who Should Use GLYCOPRESS™? GLYCOPRESS™ is suitable for adults diagnosed with chronic obstructive pulmonary disease who require consistent, long-term airway management. It is particularly beneficial for: Patients who experience persistent daily symptoms Individuals who require nebulized medication delivery Patients needing a non-steroidal maintenance bronchodilator Those seeking improved respiratory stability and quality of life It is not recommended for pediatric patients unless specifically directed by a healthcare professional. Quality and Reliability GLYCOPRESS™ is manufactured under strict pharmaceutical quality standards to ensure consistent dosing accuracy, sterility, and safety. Each 25 mcg dose is carefully formulated to deliver precise bronchodilation while minimizing systemic absorption. Its inhalation solution format ensures even dispersion and efficient lung deposition when used with an appropriate nebulizer system. Lifestyle Support with GLYCOPRESS™ While GLYCOPRESS™ plays a critical role in COPD management, optimal results are achieved when combined with: Smoking cessation Pulmonary rehabilitation programs Regular exercise as advised Balanced nutrition Routine medical follow-up Patients are encouraged to monitor symptoms regularly and maintain open communication with their healthcare provider. Conclusion GLYCOPRESS™ (Glycopyrrolate / Glycopyrronium Inhalation Solution 25 mcg) represents a reliable, long-acting bronchodilator option for individuals managing chronic obstructive pulmonary disease. By targeting airway muscle constriction at its source, GLYCOPRESS™ promotes sustained bronchodilation, improved airflow, and enhanced breathing comfort.
